Company / Depreciation & Amortization
ATOSSA THERAPEUTICS, INC. Depreciation & Amortization History
FY2012-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$272.6K
FY2016
5-year range
$15.6K / $480.3K
FY2012-FY2016
Trend
-43.2%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $472,934 to $272,627 over the past 2 years.
Based on SEC 10-K filings.
$272,627 in FY2016 with a 3-year CAGR of +27.8%.
Improved from $472,934 to $272,627 over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +27.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of +27.8%, indicating consistent growth.
- In FY2016, depreciation & amortization decreased 43.2% year-over-year.
- Peak depreciation & amortization was recorded in FY2015.
- Lowest depreciation & amortization in the period was in FY2012.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -15.14 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2016 | $272.6K | -43.2% |
| FY2015 | $480.3K | +1.6% |
| FY2014 | $472.9K | +262.3% |
| FY2013 | $130.6K | +735.6% |
| FY2012 | $15.6K | - |
As of FY2016 · SEC 10-K · Updated Jun 24, 2026